動画検索
関連広告
検索結果
Branches in the Influenza Merging Infectious Disease Division
Flu Vaccines
Microneedle Patches
Strategy To Mitigate the Next Pandemic
Background
Pre-Exposure Prophylaxis
Vaccine Effectiveness
Requirements for Barta
Potent Adjuvants Induce Cross-Stream Protection and Influenza and Several Other Viral Infections Is There a Plan To Stockpile Adjuvants
Why Have We Limited the Prep Effort to Products Which Require Only One Dose with a Six Month Duration
Engagement
Clinical Laboratory Networks Clinical Development Networks
Non-Clinical Partnerships with Industry
Partners in the Non-Clinical Development Chemical
Studies across Non-Clinical Studies
Development of Medical Countermeasures against Chemical Threat
Data Operations Branch
Priorities for Fiscal Year 2023 for Barta's Non-Clinical Development
Can Others Gain Access to the Models